Broad Genomic Sequencing Extends Advanced Lung Cancer Survival
Broad genomic sequencing extended overall survival in advanced non-small cell lung cancer patients by an average of two months when performed before first-line treatment. The research, published in the November 2026 issue of the JNCCN-Journal of the National Comprehensive Cancer Network, analyzed real-world data from the Flatiron Health Research Database. The study examined more than … Read more